138
Participants
Start Date
July 3, 2014
Primary Completion Date
September 20, 2015
Study Completion Date
December 22, 2015
F-627
F-627 at doses of 10 mg/dose or 20 mg/dose, s.c. on Day 3 of each cycle for up to 4 cycles.
Filgrastim
Filgrastim at dose of 5 mcg/kg/day for up to 2 weeks, s.c. start from Day 3 of each cycle for up to 4 cycles.
Fudan University Shanghai Cancer Center, Shanghai
Lead Sponsor
Fudan University
OTHER
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
OTHER
Nanfang Hospital, Southern Medical University
OTHER
The Affiliated Hospital of Qingdao University
OTHER
Tongji Hospital
OTHER
The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China
OTHER
RenJi Hospital
OTHER
Zhejiang Cancer Hospital
OTHER
Yunnan Cancer Hospital
OTHER
Henan Cancer Hospital
OTHER_GOV
Jiangsu Provincial People's Hospital
OTHER
Huaxi Hospital
OTHER
EVIVE Biotechnology
INDUSTRY